Microcap Ledger Advanced Biomed Inc. $ADVB
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
This page is still filling in. We publish more sections as filings are processed.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Services-Medical Laboratories
- Headquarters
- Reno, NV
- Fiscal year end
- June 30
- Shares outstanding
- 1,382,133 [10-Q 2026-05-15]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 9 months to Mar 2026 | — | $5.98M | −$1.36M | $2.60M | [10-Q 2026-05-15] |
| FY ended Jun 2025 | — | −$3.26M | −$5.83M | $2.87M | [10-K 2025-10-08] |
| FY ended Jun 2024 | — | −$2.78M | −$2.13M | $2.61M | [10-K 2025-10-08] |
- Quarterly cash burn
- −$454.6K
- Cash runway Estimate
- ~17.2 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2025-03-31 | 21,640,000 | [10-Q 2025-05-15] |
| 2025-10-08 | 21,640,000 | [10-K 2025-10-08] |
| 2025-11-19 | 21,640,000 | [10-Q 2025-11-19] |
| 2025-12-31 | 21,640,000 | [10-Q 2026-02-13] |
| 2026-03-31 | 1,382,133 | [10-Q 2026-05-15] |
- Shelf registration
- S-1 filed 2025-07-23; no effectiveness notice found in EDGAR [S-1 2025-07-23]
Listing status
Current status: 2 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-01-21. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-01-21 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-01-21] |
| 2025-07-24 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-07-24] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-27 | Pau Hung To | other | 100,000 | $480000.00 | [4 2026-08-20] |
| 2026-07-27 | Pau Hung To | other | 76,225 | $480000.00 | [4 2026-08-20] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-28 | NT 10-K | Notice of late annual report |
| 2026-09-22 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-08-20 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-20 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-07-17 | 8-K | Material agreement terminated |
| 2026-07-01 | 8-K | Shareholder vote results |
| 2026-06-30 | 8-K | Material agreement entered |
| 2026-06-04 | DEF 14A | Proxy statement |
| 2026-05-15 | 10-Q | Quarterly report |
| 2026-05-01 | 8-K | Acquisition or disposition completed; Unregistered sale of equity; Director or officer change |
| 2026-04-14 | 8-K | Material agreement entered |
| 2026-04-03 | 8-K | Material agreement entered |
Alerts for $ADVB
Email me when Advanced Biomed Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.